Interleukin-17A Antagonist [EPC]

124516 reported adverse events

Drugs of this class: IXEKIZUMAB SECUKINUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-17A Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 19681
1 PSORIASIS 16854
2 PAIN 9183
3 ARTHRALGIA 8225
4 MALAISE 5609
5 PRURITUS 5365
6 FATIGUE 5086
7 INJECTION SITE PAIN 4578
8 DIARRHOEA 4536
9 PSORIATIC ARTHROPATHY 4464
See all common reactions for Interleukin-17A Antagonist [EPC]

Drugs of the Interleukin-17A Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND PSORIASIS 108 0.4154
1 RED BLOOD CELL SEDIMENTATION RATE 69 0.3467
2 TONSILLAR ULCER 41 0.3445
3 MACULE 566 0.2889
4 DACTYLITIS 165 0.2855
5 ENTHESOPATHY 290 0.2805
6 NAIL PSORIASIS 93 0.2703
7 SERONEGATIVE ARTHRITIS 131 0.2620
8 SKIN PLAQUE 1242 0.2245
9 PSORIATIC ARTHROPATHY 4464 0.2022
See all enriched reactions for Interleukin-17A Antagonist [EPC]